Elevate your drug lifecycle strategy with Curexbios Scientific Affairs solutions. We integrate protocol development, advanced biostatistics (PK/PD modeling), and expert scientific writing to transform clinical raw data into submission-ready regulatory dossiers. Backed by independent DRC & DSMB boards, our cross-functional team ensures data integrity, patient safety, and seamless alignment with global FDA, EMA, and ICH-GCP regulatory compliance standards.